secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theriva Biologics, Inc. (TOVX)
CIK:        0000894158
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001104659-25-046170
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Theriva Biologics closes $7.5M public offering of common stock and warrants
---------------------------------------------------------------------------

- Gross proceeds of ~$7.5M from offering of 6.8M shares (or pre-funded warrants) and common warrants at $1.10/unit.
- Offering includes 1.99M shares, 4.83M pre-funded warrants, and 6.82M common warrants exercisable at $1.10 for 5 years.
- Proceeds primarily for working capital, R&D, and manufacturing scale-up; no acquisition commitments.
- Post-closing shares outstanding: 4,773,358 (excluding warrants).
- A.G.P./Alliance Global Partners acted as placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/894158/000110465925046170/0001104659-25-046170-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/894158/000110465925046170/tm2514447d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-046170

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer